Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal disc Preservation and Anular Repair (TM) products, announced that the Company's Board of Directors has appointed Richard Lunsford as President and Chief Executive Officer and the Company's shareholders have elected him to the Board of Directors. Michael McCormick, the previous CEO has resigned to pursue other interests. Mr. Lunsford brings decades of senior management experience in the development and commercialization of innovative medical devices. Anulex has obtained United States Food and Drug Administration clearance for its Inclose and Xclose soft tissue repair products and is commercializing these products in the United States.

Anulex Technologies, Inc. is a privately held company dedicated to the development and commercialization of unique and proprietary soft tissue repair products with primary interests in treatments for the soft tissues of the spine. Back injuries afflict four out of every five individuals at some point during their life, and it is a major cause of disability. Xclose, Inclose and Anulex are registered trademarks of Anulex Technologies, Inc. in the United States. More information on the Company can be found at www.anulex.com.

More Voices